MedPath

Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital

Recruiting
Conditions
Extremely Premature Newborn (Born Before 32 Weeks' Gestation)
Interventions
Other: Collection of brain and kidney NIRS measurements
Other: echocardiography
Registration Number
NCT06153771
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

Monitoring patent ductus arteriosus is currently performed using echocardiography, an operator-dependent examination which requires holding the child on their back and which is potentially time-consuming. This test is usually carried out on days 2, 4 and 7 after birth.

NIRS (near-infrared spectroscopy) is a non-invasive method of monitoring tissue oxygen saturation using infrared light.

The aim of the study was to investigate an association between cerebral and renal NIRS data and ductus arteriosus status obtained by echocardiography.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Parent who has agreed to participate in the study
  • Very premature newborn (born before 32 weeks' gestation)
  • Hospitalised in the Neonatal Intensive Care Unit at Dijon University Hospital
  • Before 48 hours of life
Exclusion Criteria
  • Newborn with congenital heart disease
  • Newborn with a congenital renal anomaly
  • Newborn with polymalformative syndrome
  • Newborn with a skin anomaly
  • Newborn with severe circulatory failure unrelated to the ductus arteriosus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Extremely premature newbornCollection of brain and kidney NIRS measurements(born before 32 weeks' gestation)
Extremely premature newbornechocardiography(born before 32 weeks' gestation)
Primary Outcome Measures
NameTimeMethod
The ultrasound status of the ductus arteriosusOn day 2, day 4 and day 7 of life

(haemodynamically significant open, non-haemodynamically significant open, closed)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Dijon Bourgogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath